Found: 37
Select item for more details and to access through your institution.
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 9, p. 2437, doi. 10.1007/s00520-013-1808-5
- By:
- Publication type:
- Article
Daratumumab monotherapy for relapsed POEMS syndrome.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E291, doi. 10.1002/ajh.27050
- By:
- Publication type:
- Article
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 719, doi. 10.1002/ajh.26536
- By:
- Publication type:
- Article
Progression with clinical features is associated with worse subsequent survival in multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 439, doi. 10.1002/ajh.25415
- By:
- Publication type:
- Article
A Unique Case of Combined Nodular and Tracheobronchial Amyloidosis.
- Published in:
- Oxford Medical Case Reports, 2021, v. 2021, n. 2, p. 1, doi. 10.1093/omcr/omaa134
- By:
- Publication type:
- Article
Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia).
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Precursor T Cell Acute Lymphoblastic Lymphoma Presenting as Bilateral Facial Nerve Palsy.
- Published in:
- Chemotherapy (0009-3157), 2010, v. 56, n. 3, p. 258, doi. 10.1159/000316847
- By:
- Publication type:
- Article
Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 857, doi. 10.1016/j.clml.2023.07.007
- By:
- Publication type:
- Article
NS-62: The Importance of regular disease monitoring for patients with low or low intermediate risk Monoclonal Gammopathy of Undetermined Significance (MGUS).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S166, doi. 10.1016/S2152-2650(21)02356-9
- By:
- Publication type:
- Article
Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients.
- Published in:
- 2020
- By:
- Publication type:
- case study
Ibrutinib is Effective in Refractory Type II Cryoglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lenalidomide-Related Diarrhea Correlates with Disease Control in Newly-Diagnosed Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e341, doi. 10.1016/j.clml.2019.09.563
- By:
- Publication type:
- Article
An Advanced Practice Provider-led, Outpatient Consult Clinic for Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Plasma Cell Disorders (PCDs): The Cleveland Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e342, doi. 10.1016/j.clml.2019.09.565
- By:
- Publication type:
- Article
A Phase 1/2 Trial of Low-Dose Continuous Azacitidine in Combination with Lenalidomide and Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e262, doi. 10.1016/j.clml.2019.09.434
- By:
- Publication type:
- Article
Real World Data on the Safety and Efficacy of Pomalidomide as a Single Agent and in Combination with Corticosteroids in Relapsed and Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e240, doi. 10.1016/j.clml.2019.09.399
- By:
- Publication type:
- Article
Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Solitary extramedullary plasmacytoma of the penis.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Current Novel Targeted Therapeutic Strategies in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6192, doi. 10.3390/ijms25116192
- By:
- Publication type:
- Article
Disparities in time to treatment with oral antimyeloma medications.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01128-1
- By:
- Publication type:
- Article
Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00397-w
- By:
- Publication type:
- Article
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 280, doi. 10.1111/bjh.18630
- By:
- Publication type:
- Article
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 6, p. 1213, doi. 10.1111/bjh.17505
- By:
- Publication type:
- Article
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. 1074, doi. 10.1111/bjh.16488
- By:
- Publication type:
- Article
Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. 1136, doi. 10.1111/bjh.16454
- By:
- Publication type:
- Article
Daratumumab proves safe and highly effective in AL amyloidosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 342, doi. 10.1111/bjh.15455
- By:
- Publication type:
- Article
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0172996
- By:
- Publication type:
- Article
Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development.
- Published in:
- Antibodies (2073-4468), 2019, v. 8, n. 2, p. 34, doi. 10.3390/antib8020034
- By:
- Publication type:
- Article
Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2160, doi. 10.3390/cancers15072160
- By:
- Publication type:
- Article
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3293
- By:
- Publication type:
- Article
Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of early palliative care integration on patients with newly diagnosed multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 7, p. 1, doi. 10.1007/s00520-024-08665-2
- By:
- Publication type:
- Article
Myonecrosis in Sickle Cell Anemia--Overlooked and Underdiagnosed.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Pomalidomide-based maintenance post-autologous hematopoietic cell transplantation in multiple myeloma: a case series.
- Published in:
- 2019
- By:
- Publication type:
- case study
Supra-normal left ventricular ejection fraction in cardiac amyloidosis.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2016, v. 6, p. 21, doi. 10.2147/BLCTT.S90764
- By:
- Publication type:
- Article
Emerging Advances in the Management of Cardiac Amyloidosis.
- Published in:
- Current Cardiology Reports, 2015, v. 17, n. 11, p. 1, doi. 10.1007/s11886-015-0653-1
- By:
- Publication type:
- Article